Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study (Q46636395)
Jump to navigation
Jump to search
scientific article published on 13 December 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study |
scientific article published on 13 December 2017 |
Statements
1 reference
Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study (English)
1 reference
Andrew N Phillips
Andreas Ronit
Shweta Sharma
Jason V Baker
Rosie Mngqibisa
Luis Caldeira
Nicaise Ndembi
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Strategic Timing of Antiretroviral Treatment (START) Study Group
13 December 2017
1 reference
1 reference
1 reference
1 reference